As a part of Olon Group, Olon Ricerca Bioscience can guarantee our clients long-term partnerships that include large-scale manufacturing capabilities in Europe at eight FDA-inspected manufacturing plants. In addition, access to Olon’s skilled regulatory team, that manage more than 350 DMF’s in more than 70 countries, which has established experience in global regulatory and quality procedures, allows Ricerca Bioscience to support both large pharmaceutical companies seeking specialized services and/or complementary capacities and small and mid-sized pharmaceutical firms that have limited manufacturing infrastructure and rely on CDMOs for a range of services, including regulatory filings, quality assurance, procurement and supply management support. The close relationships that Olon has established with the global regulatory agencies will facilitate future filings for the US customers.